STRS Ohio’s Larimar Therapeutics LRMR Stock Holding History

STRS Ohio’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$80.8K	Buy	26,500 +4,800	+22%	+$19.1K	﹤0.01%	1922
2026 Q1	$97.7K	Buy	21,700 +13,800	+175%	+$55.2K	﹤0.01%	1787
2025 Q4	$30.1K	Hold	7,900	–	–	﹤0.01%	2065
2025 Q3	$25.5K	Hold	7,900	–	–	﹤0.01%	2093
2025 Q2	$22.8K	Hold	7,900	–	–	﹤0.01%	2127
2025 Q1	$17K	Hold	7,900	–	–	﹤0.01%	1859
2024 Q4	$30.6K	Hold	7,900	–	–	﹤0.01%	1780
2024 Q3	$51.7K	Hold	7,900	–	–	﹤0.01%	1798
2024 Q2	$57.3K	Hold	7,900	–	–	﹤0.01%	1782
2024 Q1	$59K	Buy	7,900 +2,600	+49%	+$20.3K	﹤0.01%	1753
2023 Q4	$24K	Hold	5,300	–	–	﹤0.01%	1838
2023 Q3	$20K	Hold	5,300	–	–	﹤0.01%	1874
2023 Q2	$16K	Buy	+5,300	New	+$21.6K	﹤0.01%	1896
2019 Q2	–	Sell	-533	Closed	-$17K	–	2164
2019 Q1	$17K	Hold	533	–	–	﹤0.01%	1980
2018 Q4	$31K	Hold	533	–	–	﹤0.01%	1943
2018 Q3	$74K	Buy	+533	New	+$64.7K	﹤0.01%	1881
2015 Q4	–	Sell	-1,700	Closed	-$651K	–	1937
2015 Q3	$651K	Sell	1,700 -50	-3%	-$22.5K	﹤0.01%	1106
2015 Q2	$727K	Buy	+1,750	New	+$732K	﹤0.01%	1116
2015 Q1	–	Sell	-200	Closed	-$94.9K	–	1844
2014 Q4	$74K	Hold	200	–	–	﹤0.01%	1572
2014 Q3	$47K	Buy	+200	New	+$45.3K	﹤0.01%	1657

Other funds holding LRMR

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

STRS Ohio's LRMR Position: Q2 2026 in Review

STRS Ohio increased its Larimar Therapeutics (LRMR) stake by 22% in Q2 2026, buying an estimated $19.1K and bringing the position to 26,500 shares worth $80.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1922.

STRS Ohio first reported a position in LRMR in Q3 2014 and has held it in 20 quarters since. The position peaked at $727K in Q2 2015. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

STRS Ohio held 26,500 shares of Larimar Therapeutics worth $80.8K as of Q2 2026.
STRS Ohio bought 4,800 Larimar Therapeutics shares in Q2 2026, an estimated $19.1K.
Larimar Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1922 holding.
STRS Ohio first reported a position in Larimar Therapeutics in Q3 2014 and has held it in 20 quarters since.
STRS Ohio's Larimar Therapeutics position peaked at $727K in Q2 2015.
163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.